Roman Necina
Operationeel Directeur bij HOOKIPA PHARMA INC.
Vermogen: 11 990 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Roman Necina
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria.
6
| Extinct | Pharmaceuticals: Major | 6 |
Austrian Academy of Sciences
 Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Roman Necina via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chief Executive Officer Chairman Director/Board Member Director/Board Member Chief Executive Officer Founder | |
| University of Vienna | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
GeneSpire Srl
 GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Chairman Director/Board Member | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IOMAI CORPORATION | Biotechnology | Founder Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Graduate Degree | |
| University of Basel | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| Osterreichische Akademie Der Wissenschaften | Corporate Officer/Principal Corporate Officer/Principal | ||
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| UNIQURE N.V. | Biotechnology | Chief Executive Officer Founder | |
| MEDIGENE AG | Biotechnology | Director/Board Member Chairman | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Graz University of Technology | College/University | Chairman | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| Salinen Austria AG | Director/Board Member | ||
| Osterreichischen Akademie Der Wissenschaften | College/University | Corporate Officer/Principal | |
| Rat Fur Forschung Und Technologieentwicklung | Corporate Officer/Principal | ||
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Österreichische Salinen AG
 Österreichische Salinen AG Other Metals/MineralsNon-Energy Minerals Österreichische Salinen AG operates as a holding company, which provides management and financing services to the Salinen Group. The company was founded on October 17, 1977 and is headquartered in Ebensee, Austria. | Other Metals/Minerals | Director/Board Member | |
Leopold Pharma Gmbh
 Leopold Pharma Gmbh Pharmaceuticals: MajorHealth Technology Leopold Pharma GmbH provides healthcare products and services to hospitals. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Sidney Kimmel Comprehensive Cancer Center
 The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services The Sidney Kimmel Comprehensive Cancer Center offers immune-based treatments for cancer. The company was founded by Sidney Kimmel in 1973 and is headquartered in Baltimore, MD. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Austrian Counsel | Director/Board Member | ||
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
| Gilead Sciences Ireland UC | Chief Operating Officer | ||
| Trinity College Dublin | College/University | Undergraduate Degree | |
| University College Cork | College/University | Corporate Officer/Principal | |
| National Standards Authority of Ireland | Chairman | ||
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Alexion Pharma International Operations Ltd.
 Alexion Pharma International Operations Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma International Operations Ltd. wholesales drugs, proprietaries and sundries. The company is based in Dublin, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Masters Business Admin | |
| Universität Salzburg | College/University | Graduate Degree | |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Baltimore Bays Soccer Club | Corporate Officer/Principal | ||
| RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
Fresenius Kabi Austria GmbH
 Fresenius Kabi Austria GmbH Pharmaceuticals: MajorHealth Technology Fresenius Kabi Austria GmbH develops and distributes IV drugs and nutrition products. It specializes in infusion and nutrition therapy. The firm offers active pharmaceutical ingredients, infusion therapy, oncology drugs, parenteral nutrition, enteral nutrition, medical devices, and hesylation. The company was founded in 1997 and is headquartered in Graz, Austria. | Pharmaceuticals: Major | Chief Executive Officer | |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AT&S - AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT | Electronic Components | Director/Board Member | |
| BDI - BIOENERGY INTERNATIONAL AG | Industrial Machinery | Director/Board Member | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 20 |
| Oostenrijk | 15 |
| Ierland | 6 |
| Duitsland | 5 |
| Italië | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 2 |
| Non-Energy Minerals | 2 |
Operationeel
| Director/Board Member | 141 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 40 |
| Chairman | 32 |
| Chief Tech/Sci/R&D Officer | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Norbert Riedel | 29 |
| David Ebsworth | 26 |
| Graziano Seghezzi | 26 |
| Thomas D. Szucs | 23 |
| Michael Kelly | 19 |
| Sander J. van Deventer | 17 |
| Julie O'Neill | 16 |
| Christoph S. Lengauer | 16 |
| Karin Schaupp | 16 |
| Jörn Aldag | 15 |
| Jan van de Winkel | 15 |
| Werner Lanthaler | 13 |
| Victor Paulus | 12 |
| Mary Coelho | 12 |
| Gerd Zettlmeissl | 11 |
- Beurs
- Insiders
- Roman Necina
- Bedrijfsconnecties